These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17225323)

  • 21. Side effects and complications. Italian study explores reasons for sexual dysfunction in men.
    TreatmentUpdate; 2005 Dec; 17(7):10. PubMed ID: 17225324
    [No Abstract]   [Full Text] [Related]  

  • 22. Concomitant presentation of multiple vertebral and peripheral osteonecrosis in a HIV-infected patient.
    Sifuentes Giraldo WA; Blázquez Cañamero M; Navas Elorza E; Gallego Rivera I; Vázquez Díaz M
    Joint Bone Spine; 2012 May; 79(3):332-4. PubMed ID: 22281227
    [No Abstract]   [Full Text] [Related]  

  • 23. Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?
    Friis-Møller N; Worm SW
    Clin Infect Dis; 2007 Oct; 45(8):1082-4. PubMed ID: 17879929
    [No Abstract]   [Full Text] [Related]  

  • 24. Can the bone disease experienced by HIV-infected patients be attributed to HAART?
    Monier P
    HIV Clin; 2003; 15(3):1-3. PubMed ID: 12945528
    [No Abstract]   [Full Text] [Related]  

  • 25. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
    Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
    Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Szczech LA
    Curr Opin HIV AIDS; 2009 May; 4(3):167-70. PubMed ID: 19532045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors.
    Gutiérrez F; Padilla S; Ortega E; García JA; Flores J; Galera C; Merino E; Masiá M; Roig P; Boix V; Portilla J; Cuadrado JM; Gregori J; Lopez J
    AIDS; 2002 Feb; 16(3):481-3. PubMed ID: 11834961
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living longer with HIV: what does it mean for cancer risk?
    Grulich AE
    Curr Opin HIV AIDS; 2009 Jan; 4(1):1-2. PubMed ID: 19339933
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.
    Chauvel O; Lacombe K; Bonnard P; Lascoux-Combe C; Molina JM; Miailhes P; Girard PM; Carrat F
    Antivir Ther; 2007; 12(7):1115-26. PubMed ID: 18018770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary hypertension in individuals with HIV infection.
    Petrosillo N; Chinello P; Cicalini S
    AIDS; 2006 Oct; 20(16):2128-9. PubMed ID: 17053364
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial comment: changes in HIV hospitalizations.
    Gebbie KM
    AIDS Read; 2007 Aug; 17(8):400. PubMed ID: 17717883
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cardiovascular risk in patients with human immunodeficiency virus infection under highly active antiretroviral therapy.
    Zangerle R; Fuchs D
    Am J Cardiol; 2008 Aug; 102(3):373-4. PubMed ID: 18638612
    [No Abstract]   [Full Text] [Related]  

  • 35. Plunging ranula in young HIV patient.
    Hershkin AT; Miller EJ
    N Y State Dent J; 2007 Nov; 73(6):46-7. PubMed ID: 18265770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-related mortality among tuberculosis patients in The Netherlands, 1993-2001.
    Haar CH; Cobelens FG; Kalisvaart NA; van Gerven PJ; van der Have JJ
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):1038-41. PubMed ID: 17918662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side effects and complications. Tesamorelin--results from Phase III.
    TreatmentUpdate; 2007; 19(3):6-7. PubMed ID: 17575575
    [No Abstract]   [Full Text] [Related]  

  • 40. Regression of HIV-associated mucosa-associated lymphoid tissue lymphoma during highly active anti-retroviral therapy.
    Ishimaru F
    Clin Infect Dis; 2008 Apr; 46(7):1124. PubMed ID: 18444837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.